ArticleSystematic reviews2026
Effectiveness of echocardiography and cardiac magnetic resonance for screening and monitoring cardiomyopathy in people living with HIV: a mixed-methods systematic review protocol.
Article in Systematic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeople living with HIV (PLWH) have a markedly increased risk of cardiovascular disease (CVD), including cardiomyopathy, due to a complex interplay of chronic inflammation, viral persistence, and antiretroviral therapy (ART) effects. Echocardiography and cardiac magnetic resonance (CMR) are key imaging tools for detecting subclinical myocardial damage, yet their comparative effectiveness and optimal use in this population remain unclear.
objectiveTo systematically evaluate the effectiveness and diagnostic accuracy of echocardiography and CMR for the early detection, structural characterization, and monitoring of cardiomyopathy in PLWH, and to explore how clinical, therapeutic, and geographic factors influence imaging findings.
methodsThis protocol follows the PRISMA-P guidelines and is registered in PROSPERO (CRD420251023451). We will include observational studies and clinical trials involving adults (≥ 18 years) with confirmed HIV infection who underwent echocardiography or CMR. Two reviewers will independently perform study selection, data extraction, and risk of bias assessment using validated tools. Narrative and quantitative syntheses will be conducted, with subgroup and meta-regression analyses by ART regimen, CD4 count, and geographic region. The certainty of evidence will be rated using GRADE. EXPECTED IMPACT: This review aims to generate evidence and information useful for defining rational protocols and guidelines for the use of echocardiography and CMR in the care of PLWH. By consolidating evidence on the applicability of these resources for the timely diagnosis and monitoring of cardiomyopathies in PLWH, it will provide elements for establishing individual care pathways and for improving the efficiency and coverage of respective healthcare. It is thus expected to benefit individuals and, also, health programs aimed at PLWH. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD420251023451.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.